Erratum: NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis (Immunity (2018) 48(1) (107–119.e4)(S1074761317305368)(10.1016/j.immuni.2017.12.007));NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis

Immunity

Volumn 48, Issue 1, 2018, Pages 107-119.e4

  Glasner, Ariella ^a   Levi, Assi ^b   Enk, Jonatan ^a   Isaacson, Batya ^a   Viukov, Sergey ^c   Orlanski, Shari ^a   Scope, Alon ^b   Neuman, Tzahi ^d   Enk, Claes D ^a   Hanna, Jacob H ^c   Sexl, Veronika ^e   Jonjic, Stipan ^f   Seliger, Barbara ^g   Zitvogel, Laurence ^h   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^f UNIVERSITY OF RIJEKA   (Croatia)

^g MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^h INSERM   (France)

Author keywords

FN1; IFN ; Ncr1; NKp46; RCM imaging; tumor metastases

Indexed keywords

FIBRONECTIN; FIBRONECTIN 1; GAMMA INTERFERON; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; UNCLASSIFIED DRUG; LY ANTIGEN; NCR1 PROTEIN, HUMAN; NCR1 PROTEIN, MOUSE;

ARTICLE; B16 CELL LINE; HUMAN; IN VIVO STUDY; LEWIS CARCINOMA; MELANOMA; METASTASIS; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; UPREGULATION; ANIMAL; CONFOCAL MICROSCOPY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MOUSE; NEOPLASM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, LY; BLOTTING, WESTERN; FEMALE; FIBRONECTINS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; MALE; MICE; MICROSCOPY, CONFOCAL; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NEOPLASM METASTASIS; NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 85040124162     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2018.01.010     Document Type: Erratum

References (61)

1. Arnold, M., Holterhues, C., Hollestein, L.M., Coebergh, J.W., Nijsten, T., Pukkala, E., Holleczek, B., Tryggvadóttir, L., Comber, H., Bento, M.J., et al. Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. J. Eur. Acad. Dermatol. Venereol. 28 (2014), 1170–1178.
2. Bar-On, Y., Glasner, A., Meningher, T., Achdout, H., Gur, C., Lankry, D., Vitenshtein, A., Meyers, A.F.A., Mandelboim, M., Mandelboim, O., Neuraminidase-mediated, NKp46-dependent immune-evasion mechanism of influenza viruses. Cell Rep. 3 (2013), 1044–1050.
3. Bar-On, Y., Seidel, E., Tsukerman, P., Mandelboim, M., Mandelboim, O., Influenza virus uses its neuraminidase protein to evade the recognition of two activating NK cell receptors. J. Infect. Dis. 210 (2014), 410–418.
4. Breunis, W.B., Tarazona-Santos, E., Chen, R., Kiley, M., Rosenberg, S.A., Chanock, S.J., Influence of cytotoxic T lymphocyte-associated antigen 4 (CTLA4) common polymorphisms on outcome in treatment of melanoma patients with CTLA-4 blockade. J. Immunother. 31 (2008), 586–590.
5. Chaushu, S., Wilensky, A., Gur, C., Shapira, L., Elboim, M., Halftek, G., Polak, D., Achdout, H., Bachrach, G., Mandelboim, O., Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease. PLoS Pathog., 8, 2012, e1002601.
6. Chernyavskiy, O., Vannucci, L., Bianchini, P., Difato, F., Saieh, M., Kubínová L., Imaging of mouse experimental melanoma in vivo and ex vivo by combination of confocal and nonlinear microscopy. Microsc. Res. Tech. 72 (2009), 411–423.
7. Clark, E.A., Golub, T.R., Lander, E.S., Hynes, R.O., Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406 (2000), 532–535.
8. Degenhardt, Y., Huang, J., Greshock, J., Horiates, G., Nathanson, K., Yang, X., Herlyn, M., Weber, B., Distinct MHC gene expression patterns during progression of melanoma. Genes Chromosomes Cancer 49 (2010), 144–154.
9. Delahaye, N.F., Rusakiewicz, S., Martins, I., Ménard, C., Roux, S., Lyonnet, L., Paul, P., Sarabi, M., Chaput, N., Semeraro, M., et al. Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. Nat. Med. 17 (2011), 700–707.
10. Desbois, M., Rusakiewicz, S., Locher, C., Zitvogel, L., Chaput, N., Natural killer cells in non-hematopoietic malignancies. Front. Immunol., 3, 2012, 395.
11. Diab, M., Vitenshtein, A., Drori, Y., Yamin, R., Danziger, O., Zamostiano, R., Mandelboim, M., Bacharach, E., Mandelboim, O., Suppression of human metapneumovirus (HMPV) infection by the innate sensing gene CEACAM1. Oncotarget 7 (2016), 66468–66479.
12. Diab, M., Glasner, A., Isaacson, B., Bar-On, Y., Drori, Y., Yamin, R., Duev-Cohen, A., Danziger, O., Zamostiano, R., Mandelboim, M., et al. NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection. Eur. J. Immunol. 47 (2017), 692–703.
13. Draghi, M., Pashine, A., Sanjanwala, B., Gendzekhadze, K., Cantoni, C., Cosman, D., Moretta, A., Valiante, N.M., Parham, P., NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection. J. Immunol. 178 (2007), 2688–2698.
14. Eckelhart, E., Warsch, W., Zebedin, E., Simma, O., Stoiber, D., Kolbe, T., Rülicke, T., Mueller, M., Casanova, E., Sexl, V., A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. Blood 117 (2011), 1565–1573.
15. Eisenbach, L., Ramanathan, R., Nelson, D.L., Biochemical studies of the excitable membrane of paramecium tetraurelia. IX. Antibodies against ciliary membrane proteins. J. Cell Biol. 97 (1983), 1412–1420.
16. Eisenbach, L., Segal, S., Feldman, M., MHC imbalance and metastatic spread in Lewis lung carcinoma clones. Int. J. Cancer 32 (1983), 113–120.
17. Elboim, M., Gazit, R., Gur, C., Ghadially, H., Betser-Cohen, G., Mandelboim, O., Tumor immunoediting by NKp46. J. Immunol. 184 (2010), 5637–5644.
18. Fauriat, C., Long, E.O., Ljunggren, H.G., Bryceson, Y.T., Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 115 (2010), 2167–2176.
19. Flaherty, K.T., Puzanov, I., Kim, K.B., Ribas, A., McArthur, G.A., Sosman, J.A., O'Dwyer, P.J., Lee, R.J., Grippo, J.F., Nolop, K., Chapman, P.B., Inhibition of mutated, activated BRAF in metastatic melanoma. N. Engl. J. Med. 363 (2010), 809–819.
20. Fuertes, M.B., Girart, M.V., Molinero, L.L., Domaica, C.I., Rossi, L.E., Barrio, M.M., Mordoh, J., Rabinovich, G.A., Zwirner, N.W., Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity. J. Immunol. 180 (2008), 4606–4614.
21. Garber, K., Natural killer cells blaze into immuno-oncology. Nat. Biotechnol. 34 (2016), 219–220.
22. Gazit, R., Gruda, R., Elboim, M., Arnon, T.I., Katz, G., Achdout, H., Hanna, J., Qimron, U., Landau, G., Greenbaum, E., et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 7 (2006), 517–523.
23. Ghadially, H., Horani, A., Glasner, A., Elboim, M., Gazit, R., Shoseyov, D., Mandelboim, O., NKp46 regulates allergic responses. Eur. J. Immunol. 43 (2013), 3006–3016.
24. Ghadially, H., Ohana, M., Elboim, M., Gazit, R., Gur, C., Nagler, A., Mandelboim, O., NK cell receptor NKp46 regulates graft-versus-host disease. Cell Rep. 7 (2014), 1809–1814.
25. Glasner, A., Ghadially, H., Gur, C., Stanietsky, N., Tsukerman, P., Enk, J., Mandelboim, O., Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1. J. Immunol. 188 (2012), 2509–2515.
26. Glasner, A., Zurunic, A., Meningher, T., Lenac Rovis, T., Tsukerman, P., Bar-On, Y., Yamin, R., Meyers, A.F., Mandeboim, M., Jonjic, S., Mandelboim, O., Elucidating the mechanisms of influenza virus recognition by Ncr1. PLoS ONE, 7, 2012, e36837.
27. Glasner, A., Roth, Z., Varvak, A., Miletic, A., Isaacson, B., Bar-On, Y., Jonjic, S., Khalaila, I., Mandelboim, O., Identification of putative novel O-glycosylations in the NK killer receptor Ncr1 essential for its activity. Cell Discov., 1, 2015, 15036.
28. Glasner, A., Simic, H., Miklić K., Roth, Z., Berhani, O., Khalaila, I., Jonjic, S., Mandelboim, O., Expression, function, and molecular properties of the killer receptor Ncr1-Noé. J. Immunol. 195 (2015), 3959–3969.
29. Glasner, A., Isaacson, B., Viukov, S., Neuman, T., Friedman, N., Mandelboim, M., Sexl, V., Hanna, J.H., Mandelboim, O., Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression. Sci. Rep., 7, 2017, 13090.
30. Gur, C., Porgador, A., Elboim, M., Gazit, R., Mizrahi, S., Stern-Ginossar, N., Achdout, H., Ghadially, H., Dor, Y., Nir, T., et al. The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat. Immunol. 11 (2010), 121–128.
31. Gur, C., Enk, J., Kassem, S.A., Suissa, Y., Magenheim, J., Stolovich-Rain, M., Nir, T., Achdout, H., Glaser, B., Shapiro, J., et al. Recognition and killing of human and murine pancreatic beta cells by the NK receptor NKp46. J. Immunol. 187 (2011), 3096–3103.
32. Gur, C., Doron, S., Kfir-Erenfeld, S., Horwitz, E., Abu-Tair, L., Safadi, R., Mandelboim, O., NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis. Gut 61 (2012), 885–893.
33. Gur, C., Coppenhagen-Glazer, S., Rosenberg, S., Yamin, R., Enk, J., Glasner, A., Bar-On, Y., Fleissig, O., Naor, R., Abed, J., et al. Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells. Cell Host Microbe 14 (2013), 664–674.
34. Gur, C., Enk, J., Weitman, E., Bachar, E., Suissa, Y., Cohen, G., Schyr, R.B., Sabanay, H., Horwitz, E., Glaser, B., et al. The expression of the beta cell-derived autoimmune ligand for the killer receptor nkp46 is attenuated in type 2 diabetes. PLoS ONE, 8, 2013, e74033.
35. Gur, C., Ibrahim, Y., Isaacson, B., Yamin, R., Abed, J., Gamliel, M., Enk, J., Bar-On, Y., Stanietsky-Kaynan, N., Coppenhagen-Glazer, S., et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42 (2015), 344–355.
36. Guy, G.P., Ekwueme, D.U., Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature. Pharmacoeconomics 29 (2011), 863–874.
37. Halfteck, G.G., Elboim, M., Gur, C., Achdout, H., Ghadially, H., Mandelboim, O., Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1. J. Immunol. 182 (2009), 2221–2230.
38. Jarahian, M., Watzl, C., Fournier, P., Arnold, A., Djandji, D., Zahedi, S., Cerwenka, A., Paschen, A., Schirrmacher, V., Momburg, F., Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase. J. Virol. 83 (2009), 8108–8121.
39. Jarahian, M., Fiedler, M., Cohnen, A., Djandji, D., Hämmerling, G.J., Gati, C., Cerwenka, A., Turner, P.C., Moyer, R.W., Watzl, C., et al. Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin. PLoS Pathog., 7, 2011, e1002195.
40. Koch, J., Steinle, A., Watzl, C., Mandelboim, O., Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Trends Immunol. 34 (2013), 182–191.
41. Kudo-Saito, C., Shirako, H., Takeuchi, T., Kawakami, Y., Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 15 (2009), 195–206.
42. Lakshmikanth, T., Burke, S., Ali, T.H., Kimpfler, S., Ursini, F., Ruggeri, L., Capanni, M., Umansky, V., Paschen, A., Sucker, A., et al. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J. Clin. Invest. 119 (2009), 1251–1263.
43. Lamouille, S., Xu, J., Derynck, R., Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15 (2014), 178–196.
44. Li, Y., Gonzalez, S., Terwey, T.H., Wolchok, J., Li, Y., Aranda, I., Toledo-Crow, R., Halpern, A.C., Dual mode reflectance and fluorescence confocal laser scanning microscopy for in vivo imaging melanoma progression in murine skin. J. Invest. Dermatol. 125 (2005), 798–804.
45. Liu, W., Cheng, S., Asa, S.L., Ezzat, S., The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis. Cancer Res. 68 (2008), 8104–8112.
46. Mandelboim, O., Lieberman, N., Lev, M., Paul, L., Arnon, T.I., Bushkin, Y., Davis, D.M., Strominger, J.L., Yewdell, J.W., Porgador, A., Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409 (2001), 1055–1060.
47. Morvan, M.G., Lanier, L.L., NK cells and cancer: you can teach innate cells new tricks. Nat. Rev. Cancer 16 (2016), 7–19.
48. Parakh, S., Park, J.J., Mendis, S., Rai, R., Xu, W., Lo, S., Drummond, M., Rowe, C., Wong, A., McArthur, G., et al. Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases. Br. J. Cancer 116 (2017), 1558–1563.
49. Park, J., Mroz, P., Hamblin, M.R., Yaroslavsky, A.N., Dye-enhanced multimodal confocal microscopy for noninvasive detection of skin cancers in mouse models. J. Biomed. Opt., 15, 2010, 026023.
50. Pellacani, G., Guitera, P., Longo, C., Avramidis, M., Seidenari, S., Menzies, S., The impact of in vivo reflectance confocal microscopy for the diagnostic accuracy of melanoma and equivocal melanocytic lesions. J. Invest. Dermatol. 127 (2007), 2759–2765.
51. Porgador, A., Feldman, M., Eisenbach, L., H-2Kb transfection of B16 melanoma cells results in reduced tumourigenicity and metastatic competence. J. Immunogenet. 16 (1989), 291–303.
52. Rankin, L.C., Girard-Madoux, M.J., Seillet, C., Mielke, L.A., Kerdiles, Y., Fenis, A., Wieduwild, E., Putoczki, T., Mondot, S., Lantz, O., et al. Complementarity and redundancy of IL-22-producing innate lymphoid cells. Nat. Immunol. 17 (2016), 179–186.
53. Satoh-Takayama, N., Dumoutier, L., Lesjean-Pottier, S., Ribeiro, V.S., Mandelboim, O., Renauld, J.C., Vosshenrich, C.A., Di Santo, J.P., The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium. J. Immunol. 183 (2009), 6579–6587.
54. Seidel, E., Glasner, A., Mandelboim, O., Virus-mediated inhibition of natural cytotoxicity receptor recognition. Cell. Mol. Life Sci. 69 (2012), 3911–3920.
55. Sengupta, S., Nandi, S., Hindi, E.S., Wainwright, D.A., Han, Y., Lesniak, M.S., Short hairpin RNA-mediated fibronectin knockdown delays tumor growth in a mouse glioma model. Neoplasia 12 (2010), 837–847.
56. Sheppard, S., Triulzi, C., Ardolino, M., Serna, D., Zhang, L., Raulet, D.H., Guerra, N., Characterization of a novel NKG2D and NKp46 double-mutant mouse reveals subtle variations in the NK cell repertoire. Blood 121 (2013), 5025–5033.
57. Vitenshtein, A., Charpak-Amikam, Y., Yamin, R., Bauman, Y., Isaacson, B., Stein, N., Berhani, O., Dassa, L., Gamliel, M., Gur, C., et al. NK cell recognition of Candida glabrata through binding of NKp46 and NCR1 to fungal ligands Epa1, Epa6, and Epa7. Cell Host Microbe 20 (2016), 527–534.
58. Wensveen, F.M., Jelenčić V., Valentić S., Šestan, M., Wensveen, T.T., Theurich, S., Glasner, A., Mendrila, D., Štimac, D., Wunderlich, F.T., et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat. Immunol. 16 (2015), 376–385.
59. Wisco, O.J., Sober, A.J., Prognostic factors for melanoma. Dermatol. Clin. 30 (2012), 469–485.
60. Xu, L., Shen, S.S., Hoshida, Y., Subramanian, A., Ross, K., Brunet, J.P., Wagner, S.N., Ramaswamy, S., Mesirov, J.P., Hynes, R.O., Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Mol. Cancer Res. 6 (2008), 760–769.
61. Yi, M., Ruoslahti, E., A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis. Proc. Natl. Acad. Sci. USA 98 (2001), 620–624.